Company intelligence / Profile preview

Stanford Group Company

Houston, Texas, United States

Ownership: Private
Development stage: Other

Overview

Stanford Group Company was a Houston-based investment bank and broker-dealer that operated as a subsidiary of the Stanford Financial Group. While not a biotechnology or pharmaceutical developer itself, the firm was highly prominent in the life sciences sector through its specialized healthcare equity research and investment banking divisions. The company provided capital raising, M&A advisory, and market analysis for numerous emerging biotech and medical technology firms before its operations were halted in 2009. The firm was ultimately shuttered following the exposure of a multi-billion dollar Ponzi scheme orchestrated by its chairman, Allen Stanford.

Industry: Investors

Beyond the preview

Go deeper on Stanford Group Company.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stanford Group Company.

Explore the full profile